US health regulators make it easier to approve new infection detection devices

The US Food and Drug Administration (FDA) has created a new regulatory category for devices that detect infections by measuring non-microbial substances. This change moves these devices into a lower-risk classification, which means they will face fewer hurdles to get approved and reach patients.

For years, new medical devices often faced a slow and expensive approval process, especially if they didn't fit neatly into existing categories. This new classification means that companies developing innovative ways to detect infections can get their products to market faster. It specifically targets devices that look for the body's response to an infection, rather than the microbes themselves, which could lead to earlier and more accurate diagnoses.